Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 16596303)

1.

Individual variations in serum melatonin levels through time: implications for epidemiologic studies.

Nogueira LM, Sampson JN, Chu LW, Yu K, Andriole G, Church T, Stanczyk FZ, Koshiol J, Hsing AW.

PLoS One. 2013 Dec 23;8(12):e83208. doi: 10.1371/journal.pone.0083208. eCollection 2013.

2.

Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks.

Rondanelli M, Faliva MA, Perna S, Antoniello N.

Aging Clin Exp Res. 2013 Oct;25(5):499-510. doi: 10.1007/s40520-013-0118-6. Epub 2013 Sep 18. Review.

4.

Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes.

Rossetti S, Esposito J, Corlazzoli F, Gregorski A, Sacchi N.

Cell Cycle. 2012 Jan 15;11(2):350-60. doi: 10.4161/cc.11.2.18792. Epub 2012 Jan 15.

5.

Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in young but not in old rats.

Vinogradova IA, Anisimov VN, Bukalev AV, Ilyukha VA, Khizhkin EA, Lotosh TA, Semenchenko AV, Zabezhinski MA.

Aging (Albany NY). 2010 Mar 20;2(2):82-92.

6.

Circadian rhythm and its role in malignancy.

Rana S, Mahmood S.

J Circadian Rhythms. 2010 Mar 31;8:3. doi: 10.1186/1740-3391-8-3.

7.

Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats.

Vinogradova IA, Anisimov VN, Bukalev AV, Semenchenko AV, Zabezhinski MA.

Aging (Albany NY). 2009 Oct 2;1(10):855-65.

8.

Light-at-night, circadian disruption and breast cancer: assessment of existing evidence.

Stevens RG.

Int J Epidemiol. 2009 Aug;38(4):963-70. doi: 10.1093/ije/dyp178. Epub 2009 Apr 20.

9.

Ill-lighting syndrome: prevalence in shift-work personnel in the anaesthesiology and intensive care department of three Italian hospitals.

Morghen I, Turola MC, Forini E, Di Pasquale P, Zanatta P, Matarazzo T.

J Occup Med Toxicol. 2009 Mar 27;4:6. doi: 10.1186/1745-6673-4-6.

10.

Circulating melatonin and the risk of breast and endometrial cancer in women.

Viswanathan AN, Schernhammer ES.

Cancer Lett. 2009 Aug 18;281(1):1-7. doi: 10.1016/j.canlet.2008.11.002. Epub 2008 Dec 12. Review.

11.

The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.

Hoffman AE, Zheng T, Ba Y, Zhu Y.

Mol Cancer Res. 2008 Sep;6(9):1461-8. doi: 10.1158/1541-7786.MCR-07-2094.

12.

Sleep duration, melatonin and breast cancer among Chinese women in Singapore.

Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP, Yu MC.

Carcinogenesis. 2008 Jun;29(6):1244-8. doi: 10.1093/carcin/bgn100. Epub 2008 Apr 30.

13.

Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases.

Stevens RG, Blask DE, Brainard GC, Hansen J, Lockley SW, Provencio I, Rea MS, Reinlib L.

Environ Health Perspect. 2007 Sep;115(9):1357-62.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk